$RAPH 8-K/A SEC Filings

Filed On	Filing
26 Jan 2023	8-K/A: Departure/Election of Directors or Officers; Compensation This SERVICE AGREEMENT (this “Agreement”) is made as of 5th of July, 2022, by and between Raphael Pharmaceutical INC. (the “Company”),, and DR. IGAL LOURIA HAYON (the “CTO”/so called “IGAL”).
10 Sep 2009	8-K/A: Changes in Registrant's Certifying Accountant
07 Jul 2008	8-K/A: Financial Statements and Exhibits

Comments